Detalhe da pesquisa
1.
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years.
N Engl J Med
; 388(3): 214-227, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652353
2.
Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial.
Vaccines (Basel)
; 12(2)2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400102
3.
Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination.
Infect Dis Ther
; 13(4): 699-714, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38489117
4.
Comparison of the effects of levofloxacin on QT/QTc interval assessed in both healthy Japanese and Caucasian subjects (pages.
Br J Clin Pharmacol
; 73(3): 455-9, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22442827